About AKI screening

Pathology results sent to Nervecentre can trigger clinical rules for AKI screening. The clinical rules state what happens if a patient has a certain stage of AKI.

If a result says a patient has AKI, Nervecentre updates the clinical note for AKI and adds a patient tag to the patient banner. Clinicians can view the clinical note and patient tag immediately on mobile and desktop.

During the day, if a result says a patient has AKI Stage 2, Nervecentre sends a task to all nurses in the critical care outreach team (CCOT Critical Care Outreach Team.). If all nurses in the CCOT are unavailable or decline the task, Nervecentre sends an alert to the nurse in charge (NIC) Nurse In Charge.

During the day, if a result says a patient has AKI Stage 3, Nervecentre sends a task to all doctors who have the patient on their patient list. If all doctors are unavailable or decline the task, Nervecentre sends the task to all registrars who have the patient on their patient list. If all registrars are unavailable or decline the task, Nervecentre sends an alert to the NIC.

At night, if a result says a patient has AKI Stage 2 or 3, a task is sent to the task screen on a desktop. The task can be manually assigned from  Tasks > Assign Tasks.

When treatment for AKI is complete, clinicians can update the clinical note ‘AKI’ to ‘AKI Resolved’. If a subsequent pathology result indicates the patient has AKI, the clinical note updates automatically again. For AKI stages 2 and 3, Nervecentre sends new AKI tasks.

Your organisation can configure who receives tasks and alerts for AKI screening. You might find that tasks for AKI are sent to different roles, for example, your hospital might not have a CCOT.

1. Pathology results are sent to Nervecentre.

   If the results say the patient has AKI Stage 1:

   • Nervecentre updates the clinical note 'AKI' to 'AKI Stage 1'.

   • Nervecentre adds an amber patient tag ‘AKI 1’ to the patient banner.

2. When treatment for AKI is complete, a clinician must manually update the clinical note ‘AKI’ to ‘AKI Resolved’.

1. Pathology results are sent to Nervecentre.

   If the results say the patient has AKI Stage 2:

   • Nervecentre updates the clinical note 'AKI' to 'AKI Stage 2'.

   • Nervecentre adds an red patient tag ‘AKI 2’ to the patient banner.

   • During the day, Nervecentre sends the ‘AKI Stage 2’ task to all nurses in CCOT Critical Care Outreach Team..

   • At night, the ‘AKI Stage 2’ task appears in the list of unassigned tasks. A co-ordinator assigns the task to a clinician.

2. A clinician is offered the ‘AKI Stage 2’ task. The clinician can accept or decline the task.

   • If no nurses in CCOT accept the task after 15 minutes, Nervecentre sends an alert to the NIC Nurse In Charge.

3. The clinician that accepted the ‘AKI Stage 2’ task can choose progress options to progress the task.

4. When treatment for AKI is complete, a clinician must manually update the clinical note ‘AKI’ to ‘AKI Resolved’.

Your organisation can configure who receives tasks and alerts for AKI screening. You might find that tasks for AKI are sent to different roles, for example, your hospital might not have a CCOT.

1. Pathology results are sent to Nervecentre.

   If the results say the patient has AKI Stage 3:

   • Nervecentre updates the clinical note 'AKI' to 'AKI Stage 3'.

   • Nervecentre adds an red patient tag ‘AKI 3’ to the patient banner.

   • During the day, Nervecentre sends the ‘AKI Stage 3’ task to all doctors who have the patient on their patient list.

   • At night, the ‘AKI Stage 3’ task appears in the list of unassigned tasks. A co-ordinator assigns the task to a clinician.

2. A clinician is offered the ‘AKI Stage 3’ task. The clinician can accept or decline the task.

   • If no doctors accept the task after 10 minutes, Nervecentre sends the task to all registrars who have the patient on their patient list.

   • If no doctors or registrars accept the task after 15 minutes, Nervecentre sends an alert to the NIC Nurse In Charge.

3. The clinician that accepted the ‘AKI Stage 3’ task can choose progress options to progress the task.

4. When treatment for AKI is complete, a clinician must manually update the clinical note ‘AKI’ to ‘AKI Resolved’.

Nervecentre automatically updates the clinical note ‘AKI’ during the AKI screening process, except for the last step, setting ‘AKI’ to ‘AKI Resolved’, which must be manually completed.

When you view a patient's record, you can view patient tags. Patient tags appear directly under the patient's demographics.

Nervecentre updates patient tags for AKI depending on pathology results.

AKI patient tags on a mobile.

AKI patient tags on a desktop.